Sky Century Investment Inc

PINK:SKYI USA Drug Manufacturers - Specialty & Generic
Market Cap
$491.81K
Market Cap Rank
#47273 Global
#14638 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$1.05
About

Sky Century Investment, Inc. provides IT and marketing services, and RSS feeds and podcasts. The company offers technical support services, including maintenance, troubleshooting, and system upgrades; and leased high-performance servers that enables them to scale operations without significant upfront capital investment. It also sells RSS feeds of cannabis news to news organizations, websites, an… Read more

Sky Century Investment Inc (SKYI) - Net Assets

Latest net assets as of November 2025: $-313.92K USD

Based on the latest financial reports, Sky Century Investment Inc (SKYI) has net assets worth $-313.92K USD as of November 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($113.52K) and total liabilities ($427.44K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-313.92K
% of Total Assets -276.53%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Sky Century Investment Inc - Net Assets Trend (2012–2025)

This chart illustrates how Sky Century Investment Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Sky Century Investment Inc (2012–2025)

The table below shows the annual net assets of Sky Century Investment Inc from 2012 to 2025.

Year Net Assets Change
2025-05-31 $-285.71K -56.15%
2024-05-31 $-182.97K -100.86%
2023-05-31 $-91.09K +60.22%
2022-05-31 $-228.98K -198.42%
2021-05-31 $-76.73K -7.46%
2020-05-31 $-71.40K -124.79%
2014-05-31 $-31.77K -129.42%
2013-05-31 $-13.85K -478.82%
2012-05-31 $3.65K --

Equity Component Analysis

This analysis shows how different components contribute to Sky Century Investment Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 92034600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (May 2025)

Component Amount Percentage
Other Components $636.98K %
Total Equity $-285.71K 100.00%

Sky Century Investment Inc Competitors by Market Cap

The table below lists competitors of Sky Century Investment Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sky Century Investment Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -182,965 to -285,707, a change of -102,742.
  • Net loss of 117,225 reduced equity.
  • New share issuances of 29,094 increased equity.
  • Other comprehensive income increased equity by 220,639.
  • Other factors decreased equity by 235,250.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-117.22K -41.03%
Share Issuances $29.09K +10.18%
Other Comprehensive Income $220.64K +77.23%
Other Changes $-235.25K -82.34%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Sky Century Investment Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-05-31 $0.01 $0.00 x
2013-05-31 $0.00 $0.00 x
2014-05-31 $-0.03 $0.00 x
2015-05-31 $-0.03 $0.00 x
2019-05-31 $-0.09 $0.00 x
2020-05-31 $-0.06 $0.00 x
2021-05-31 $-0.07 $0.00 x
2022-05-31 $-0.21 $0.00 x
2023-05-31 $-0.05 $0.00 x
2024-05-31 $-0.08 $0.00 x
2025-05-31 $-0.13 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sky Century Investment Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -153.56%
  • • Asset Turnover: 0.68x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-4.94%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 -64.16% 0.00% 0.00x 1.37x $-2.71K
2013 0.00% 0.00% 0.00x 0.00x $-16.12K
2014 0.00% 0.00% 0.00x 0.00x $-20.09K
2015 0.00% 0.00% 0.00x 0.00x $-22.82K
2016 0.00% 0.00% 0.00x 0.00x $-17.45K
2017 0.00% 0.00% 0.00x 0.00x $-6.85K
2019 0.00% 0.00% 0.00x 0.00x $-10.08K
2020 0.00% 78.22% 0.15x 0.00x $35.27K
2021 0.00% -6.94% 0.38x 0.00x $2.35K
2022 0.00% -347.94% 0.21x 0.00x $-189.35K
2023 0.00% -258.98% 0.50x 0.00x $-184.51K
2024 0.00% -557.96% 0.58x 0.00x $-154.11K
2025 0.00% -153.56% 0.68x 0.00x $-88.65K

Industry Comparison

This section compares Sky Century Investment Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Sky Century Investment Inc (SKYI) $-313.92K -64.16% N/A $2.07K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million